Eli Lilly and Company (LLY)

Index:

S&P 100

$ 1,028.83
   
  • Change Today:
    $-13.32
  • 52 Week High: $1,109.94
  • 52 Week Low: $625.65
  • Currency: US Dollars
  • Shares Issued: 944.80m
  • Volume: 2,481,897
  • Market Cap: $972,039m
  • RiskGrade: 179
  • Beta: 0.01

Latest ShareCast News

Novo Nordisk slashes US prices for Wegovy, Ozempic as competition ramps up

By Benjamin Chiou

Date: Tuesday 24 Feb 2026

(Sharecast News) - Danish pharma giant Novo Nordisk is to halve the US price of obesity drug Wegovy and slash the price of diabetes treatment Ozempic from next year as competition ramps up with rival drugmaker Eli Lilly.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

LLY Market Data

Currency US Dollars
Share Price $ 1,028.83
Change Today $ -13.32
% Change -1.28 %
52 Week High $1,109.94
52 Week Low $625.65
Volume 2,481,897
Shares Issued 944.80m
Market Cap $972,039m
Beta 0.01
RiskGrade 179

What The Brokers Say

Strong Buy 12
Buy 12
Neutral 7
Sell 0
Strong Sell 0
Total 31
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-Feb-2026

Time Volume / Share Price
16:00 344,442 @ $1,028.83
16:00 1,040 @ $1,029.53
15:59 800 @ $1,029.37
15:59 200 @ $1,029.37
15:59 240 @ $1,029.37

Top of Page